Eisler Capital Management Ltd. Vertex Pharmaceuticals Inc Put Options Transaction History

Eisler Capital Management Ltd.

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2025 Nov 13, 2025	BUY	$366.54 - $479.53 $5.02 Million - $6.57 Million	13,700 Added 224.59%	19,800 $7.75 Million
Q2 2025 Aug 12, 2025	SELL	$421.16 - $509.5 $3.87 Million - $4.69 Million	-9,200 Reduced 60.13%	6,100 $2.72 Million
Q1 2025 May 14, 2025	BUY	$402.49 - $513.76 $3.1 Million - $3.96 Million	7,700 Added 101.32%	15,300 $7.42 Million
Q4 2024 Feb 14, 2025	BUY	$396.64 - $516.74 $3.01 Million - $3.93 Million	7,600 New	7,600 $3.06 Million

1,786

231M

1.83M

1.21M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $111B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Eisler Capital Management Ltd., based on Form 13F filings with the SEC.

Stay updated on Eisler Capital Management Ltd. with notifications on news.